Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera

investors.com/news/technology/metsera-novo-nordisk-pfizer-acquisition

kicked off a new battle with Pfizer (PFE) on Thursday by making an unsolicited $6.5 billion bid for obesity-focused takeover target, Metsera (MTSR).
The bid sent shock waves through Wall Street.
"You wouldn't have expected a GLP-1 incumbent to be bidding here," Evercore ISI analyst Umer…

This story appeared on investors.com, 2025-10-31 06:11:16.422000.
The Entire Business World on a Single Page. Free to Use →